Bioworld Financial Watch articles from March 2004

Bioworld Financial Watch archives from March 2004

Avastin: just tip of cancer immunotherapy's iceberg?
March 1, 2004... NEW YORK -- The curiosity of new investors and an apparent financial upswing (heralded partly by the opening squeak of an initial public offerings window) gained credit for drawing a record number of registrants to the Biotechnology Industry...

10 biggest U.S. gainers for the week.
March 1, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Deltagen 50.00 Third Wave Tech 37.14 Array 21.71 Eyetech 20.97 Emisphere 17.63 IntraBiotics 17.26 Questcor Pharma ...

10 biggest U.S. losers for the week.
March 1, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) SciClone -22.98 Argonaut -20.10 Cubist Pharma -18.46 NeoRx Corp. -16.57 Oxis Intl -14.29 Neurogen -14.09 Orchid -13.58...

Biotechnology company deals with other biotechnology companies: collaborations, agreements, equity participation, Dec. 31, 2003-Feb. 26, 2004.
March 1, 2004... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Dec. 31, 2003-Feb. 26, 2004 Company * Company* Type/Product Area (Country; (Country;...

Biotechnology company deals with miscellaneous companies: collaborations, agreements, equity participation, Dec. 31, 2003-Feb. 26, 2004.
March 1, 2004... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Dec. 31, 2003-Feb. 26, 2004 Company * Company * Type/Product Area (Country; Symbol) Affymetrix ...

Manufacturing, marketing and distribution agreements between biotech companies: Dec. 31, 2003-Feb. 26, 2004.
March 1, 2004... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Dec. 31, 2003-Feb. 26, 2004 Company * Company * Product (Country; (Country; Symbol) Symbol) Agencourt ...

Biotech-biotech collaborations: modified and terminated agreements, Dec. 31, 2003-Feb. 26, 2004.
March 1, 2004... Biotech-Biotech Collaborations: Modified And Terminated Agreements, Dec. 31, 2003-Feb. 26, 2004 I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; agreement Symbol)...

BioWorld stock report for public biotechnology companies.
March 1, 2004... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close WK YTD Vol 2/20 2/27...

Multi-phase III approach pays off for Adolor/GSK in Entereg efforts.
March 8, 2004... Two out of three ain't bad, as the song says, even (or especially) if you're talking about efficacy endpoints in Phase III trials. But try telling some investors that. Everything was looking good for Adolor Corp. until mid-January's Phase...

10 Biggest U.S. gainers for the week.
March 8, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Sepracor 70.01 Sepracor 19.82 Pharsight 57.35 Martek Bio 9.09 Northfield Labs 48.46 OSI Pharma ...

10 Biggest U.S. losers for the week.
March 8, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Incara Pharma -20.00 CIMALabs -1.70 Cygnus -14.29 Eyetech -1.09 Neurobio Tech -12.48 Myogen ...

Public financing of Biotechnology: February 2004.
March 8, 2004... Public Financing Of Biotechnology: February 2004 I. COMMENCED TRADING IN FEBRUARY Company Date Date Shares/ Price (Symbol) (#) Filed Comm. Units (M) INITIAL OFFERINGS ...

Other financing of public Biotechnology Companies: February 2004.
March 8, 2004... Other Financings Of Public Biotechnology Companies: February 2004 TOTAL: $1,473.08M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Raised ...

Venture Capital and Corporate Investments in Biotechnology Companies: February 2004.
March 8, 2004... Venture Capital And Corporate Investments In Biotechnology Companies: February 2004 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $366.98M Company Location Date Amt. (M) Acuity ...

Money raised by biotech in 2004: January.
March 8, 2004... Money Raised By Biotech In 2004: January Type of financing Jan. ($M) Feb. (M) Total ($M) Public offerings 352.07 997.8 1,349.9 Private biotechs 444.26 366.98 811.24 Public/other...

BioWorld stock report for public biotechnology companies.
March 8, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 2/27 3/5 Aastrom Biosci ASTM 1.39 1.47 Abgenix ...

Spinal arthritis market worthwhile as 'add-on' to existing therapies.
March 15, 2004... Industry pundits have been chanting about "consolidation" for years, using each new buyout as a way of proving their forecast--which, let's face it, is pretty much a fail-safe prediction. But another, similar-yet-not-the-same idea floated...

10 biggest U.S. gainers for the week.
March 15, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) SuperGen 40.97 Idexx Labs 4.24 Helix Biomed 37.33 MGI Pharma 3.70 Incara Pharma 18.75 SuperGen 2.86 Draxis...

10 biggest U.S. losers for the week.
March 15, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Deltagen -30.00 Genentech -5.57 Large Scale -26.85 Martek Bio -4.63 Sonus Pharma -20.34 Digene...

Clinical trials update: February 2004.
March 15, 2004... Clinical Trials Update: February 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Abbott Humira Fully human antibody Laboratories (adalimumab; designed...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: February 2004.
March 15, 2004... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: February 2004 Company * Product Description (Country; Symbol) CANCER GPC Biotech Satraplatin Oral platinum...

FDA submissions, approvals and other actions: February 2004.
March 15, 2004... FDA Submissions, Approvals And Other Actions: February 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Biogen Idec Antegren Humanized monoclonal anti- Inc. (BIIB) and ...

BioWorld stock report for public biotechnology companies.
March 15, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 3/5 3/15 WK YTD (000) Aastrom Biosci ASTM ...

'Cool' TLRs growing 'hot' in Biotech; Coley out in front.
March 22, 2004... "Toll-like receptor" sounds like a cop waiting at a highway coin basket to catch those who pass through without paying. And, in a way, that's what toll-like receptors, or TLRs, are. Found on the surfaces of antigen-presenting cells, they...

10 biggest U.S. gainers for the week.
March 22, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Deltagen 21.43 Telik 2.93 Ortec Int'l 17.19 Celgene 2.86 DepoMed 16.75 Myogen ...

10 biggest U.S. losers for the week.
March 22, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) GTC Biothera -18.85 Incara Pharma -18.42 AutoImmune -18.00 Avax Technol -15.79 Cell Genesys -15.54 Renovis -15.47 Nuvelo...

Collaborations between biotechnology companies and universities/nonprofit institutions: Nov. 25, 2003-March 18, 2004.
March 22, 2004... Collaborations between biotechnology companies and universities/nonprofit institutions: Nov. 25, 2003--March 18, 2004 Company * University/ Type Of (Country; Symbol) Nonprofit (@) Agreement ...

BioWorld stock report for public biotechnology companies.
March 22, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 3/12 3/19 Aastrom Biosci ASTM 1.39 1.4 Abgenix ABGX ...

Chiron scraps Matrix drug; diversified dream still alive.
March 29, 2004... In Greek mythology, Chiron was a centaur associated with healing--not a bad figure for a biotechnology firm to hook itself up with. But in the industry, what is Chiron Corp. known for? Quickly, now. "There is no Chiron bullet point," said...

10 biggest U.S. gainers for the week.
March 29, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Transkaryotic 57.39 Imcor 39.39 OraSure Tech 22.32 SuperGen 22.04 Vion Pharma 20.78 Immtech 18.67 Cygnus 16.00 Avant Immuno ...

10 biggest U.S. losers for the week.
March 29, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Myogen -37.31 Northwest Bio -30.00 ViroPharma -21.00 Cel-Sci -15.24 Helix Biomed -15.00 Cellegy Pharma -14.75 Lifecore Bio -14.60...

Biotech mergers and acquisitions: Dec. 18, 2003-March 18, 2004 (#).
March 29, 2004... I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Acquired * Or Merged With * Announced (Country; Symbol) (Country; Symbol) Access Keryx ...

BioWorld stock report for public biotechnology companies.
March 29, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 3/19 3/26 Aastrom Biosci ASTM 1.4 1.33 Abgenix ABGX 13.47 ...